MacroGenics Inc — Cash Flow (NASDAQ:MGNX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 111.9 M143.83 M86.96 M78.2 M68.37 M 162.47 M Cash from investing activities 7.79 M36.61 M70.72 M80.08 M149.3 M 89.57 M Cash from financing activities 174.34 M122.78 M1.66 M150.36 M960 K 69.61 M Free cash flow 105.99 M137.63 M83.34 M76.44 M64.67 M 160.18 M

News

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

MacroGenics stock falls after FDA places partial clinical hold

Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates

MacroGenics Inc earnings beat by $0.68, revenue topped estimates

MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stryker (SYK) Q3 Earnings and Revenues Beat Estimates

Top 5 Oncology Stocks to Watch According to Barclays

MacroGenics stock initiated with Overweight rating by Barclays